Ro-3306 : Kinase activity-independent role of EphA2 in the regulation of M-phase progression
CC220:Catchet-MS identifies IKZF1-targeting thalidomide analogues as novel HIV-1 latency reversal agents
MEK162 : Safety and efficacy evaluation of encorafenib plus binimetinib for the treatment of advanced BRAF-mutant melanoma patients
Avexitide :Chronic n-3 fatty acid intake enhances insulin response to oral glucose and elevates GLP-1 in high-fat diet-fed obese mice†
HS-173 : Synergistic anticancer activity of HS-173, a novel PI3K inhibitor in combination with Sorafenib against pancreatic cancer cells
SP-13786: Cancer-associated fibroblasts enhance metastatic potential of lung cancer cells through IL-6/STAT3 signaling pathway
MLN8054 : RIPK1-dependent cell death: a novel target of the Aurora kinase inhibitor Tozasertib (VX-680)